Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-20 Sale | 2026-01-21 5:17 pm | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 1,689 | $2.882 | $4,868 | 384,216 (Direct) | View |
| 2025-12-17 Sale | 2025-12-18 4:10 pm | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 48,244 | $3.673 | $177,200 | 1,470,587 (Direct) | View |
| 2025-12-17 Sale | 2025-12-18 4:09 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 7,337 | $3.667 | $26,905 | 467,525 (Direct) | View |
| 2025-12-17 Sale | 2025-12-18 4:09 pm | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 6,517 | $3.667 | $23,898 | 385,905 (Direct) | View |
| 2025-10-17 Sale | 2025-10-20 4:12 pm | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 1,248 | $2.6245 | $3,275 | 392,422 (Direct) | View |
| 2025-09-17 Sale | 2025-09-18 4:06 pm | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 6,267 | $2.804 | $17,573 | 393,670 (Direct) | View |
| 2025-09-17 Sale | 2025-09-18 4:06 pm | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 28,427 | $2.788 | $79,254 | 1,518,831 (Direct) | View |
| 2025-09-17 Sale | 2025-09-18 4:06 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 7,046 | $2.808 | $19,785 | 474,862 (Direct) | View |
| 2025-07-17 Sale | 2025-07-18 4:07 pm | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 1,304 | $1.127 | $1,470 | 399,937 (Direct) | View |
| 2025-07-17 Sale | 2025-07-18 4:05 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 11 | $1.115 | $12 | 474,462 (Direct) | View |
| 2025-06-17 Sale | 2025-06-18 6:45 pm | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 6,422 | $1.152 | $7,398 | 401,241 (Direct) | View |
| 2025-06-17 Sale | 2025-06-18 6:44 pm | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 30,474 | $1.109 | $33,796 | 1,541,488 (Direct) | View |
| 2025-06-17 Sale | 2025-06-18 6:44 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 7,229 | $1.152 | $8,328 | 474,473 (Direct) | View |
| 2025-04-17 Sale | 2025-04-21 4:04 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 108 | $0.978 | $106 | 370,218 (Direct) | View |
| 2025-04-17 Sale | 2025-04-21 4:03 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 8 | $0.964 | $8 | 481,702 (Direct) | View |
| 2025-03-18 Sale | 2025-03-19 4:03 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 3,535 | $1.483 | $5,242 | 481,710 (Direct) | View |
| 2025-03-18 Sale | 2025-03-19 4:02 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 2,433 | $1.487 | $3,618 | 370,326 (Direct) | View |
| 2025-03-18 Sale | 2025-03-19 4:02 pm | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 13,047 | $1.504 | $19,623 | 1,571,962 (Direct) | View |
| 2025-02-19 Sale | 2025-02-20 4:50 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 239 | $1.868 | $446 | 159,759 (Direct) | View |
| 2025-02-19 Sale | 2025-02-20 4:50 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 11 | $1.86 | $20 | 240,671 (Direct) | View |
| 2025-01-17 Sale | 2025-01-21 4:38 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 9 | $2.265 | $20 | 240,682 (Direct) | View |
| 2025-01-17 Sale | 2025-01-21 4:37 pm | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 123 | $2.26 | $278 | 159,998 (Direct) | View |
| 2024-12-17 Sale | 2024-12-18 4:14 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 3,245 | $2.424 | $7,866 | 240,691 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-12-04 Option Award | 2025-12-08 4:27 pm | N/A 2035-12-04 | Esperion Therapeutics Inc. | ESPR | Harlow John B. Jr. Chief Commercial Officer | 804,536 | $0 | 804,536 (Direct) | View |
| 2025-07-01 Option Award | 2025-07-02 08:21 am | N/A 2035-07-01 | Esperion Therapeutics Inc. | ESPR | THOMPSON JOHN CRAIG Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 4:10 pm | N/A 2035-05-29 | Esperion Therapeutics Inc. | ESPR | CARROLL J MARTIN Director | 77,000 | $0 | 141,650 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 4:10 pm | N/A 2035-05-29 | Esperion Therapeutics Inc. | ESPR | Fischer Seth H. Z. Director | 77,000 | $0 | 105,150 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 4:09 pm | N/A 2035-05-29 | Esperion Therapeutics Inc. | ESPR | Hoffman Robert E. Director | 12,320 | $0 | 12,320 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 4:08 pm | N/A 2035-05-29 | Esperion Therapeutics Inc. | ESPR | ROCAMBOLI STEPHEN Director | 77,000 | $0 | 113,261 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 4:08 pm | N/A 2035-05-29 | Esperion Therapeutics Inc. | ESPR | Shepard Jay Director | 77,000 | $0 | 128,599 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 4:07 pm | N/A 2035-05-29 | Esperion Therapeutics Inc. | ESPR | VITULLO NICOLE Director | 88,000 | $0 | 88,000 (Direct) | View |
| 2025-05-29 Option Award | 2025-06-02 4:06 pm | N/A 2035-05-29 | Esperion Therapeutics Inc. | ESPR | Woody Tracy M Director | 88,000 | $0 | 88,000 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-02 4:19 pm | N/A 2035-04-01 | Esperion Therapeutics Inc. | ESPR | Hoffman Robert E. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2025-03-14 Option Award | 2025-03-17 5:17 pm | N/A 2035-03-14 | Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO | 1,593,000 | $0 | 2,338,009 (Direct) | View |
| 2025-03-14 Option Award | 2025-03-17 5:16 pm | N/A 2035-03-14 | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 451,000 | $0 | 698,245 (Direct) | View |
| 2025-03-14 Option Award | 2025-03-17 5:16 pm | N/A 2035-03-14 | Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer | 404,000 | $0 | 563,759 (Direct) | View |
| 2025-03-14 Option Award | 2025-03-17 5:15 pm | N/A 2035-03-14 | Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel | 425,000 | $0 | 608,663 (Direct) | View |